The poster will showcase the design and ongoing progress of its Phase 1 study of CID-078 (NCT06577987), a first-in-class, oral macrocycle cyclin A/B RxL inhibitor. The abstract will be featured in a ...

While the cyclin-dependent kinase inhibitor AT7519 induces neutrophil apoptosis to promote inflammation resolution in preclinical models of lung inflammation, its potential efficacy in ARDS has not ...

These experiments indicate that B-9-3 may downregulate PI3K/p-PI3K protein expression in the three lung cancer cell lines (Figures 12D–F,b1–b3). In A549 cells, the protein levels of AKT/p-AKT were ...